"Partnership is in our genes" illustrates Therabel's willingness to work with other pharmaceutical companies; shared experiences enable Therabel to achieve operational excellence.

Therabel is a privately-owned pharmaceutical company that has been operating in Europe since 1945. It has expanded into several countries through organic growth and acquisitions. We build our product portfolio mainly by collaborating with other pharmaceutical companies. As a result, Therabel's partnered products enjoy the highest level of commitment and attention at all times.

Through our expertise in market access and commercialization, our aim is to make the safe and effective therapeutic solutions developed by our partners available to healthcare professionals and patients in Europe.

Continuing to establish new partnerships, Therabel is looking to strengthen and expand its presence in Europe. We believe that our long-term success lies in our commitment to a set of values and strict compliance with industry regulations. This ensures the highest quality, as well as the social and ethical responsibility of Therabel and its partners. What's more, our corporate culture and human-scale structure allow for personalized contact and the dynamic implementation of innovative approaches.

Therabel is not motivated by short-term financial results, but by medium- and long-term objectives. Its mission is to continue building on the foundations laid over fifty years ago and become one of Europe's leading partnership-based pharmaceutical companies, while remaining true to its human-scale structure, philosophy, ethics and independence.